Relay Therapeutics, Inc. (RLAY)
Relay Therapeutics stock hits 52-week and all-time high following FDA Breakthrough Therapy Designation for Zovegalisib. Social media buzz, particularly on X, surges alongside price.
About Relay Therapeutics, Inc.
Relay Therapeutics, Inc. is a biotechnology company focused on developing small molecule drugs.
Relay Therapeutics, Inc. uses the ticker $RLAY for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Relay Therapeutics, Inc. (RLAY) sentiment is up 127.27% from the previous week.
- Relay Therapeutics, Inc. Galaxy Score™ hit a 52-Week high of [--] for the hour
- Relay Therapeutics, Inc. Price hit a 52-Week high of $9.50 for the hour
- Relay Therapeutics, Inc. Price hit an all time of $9.50 for the hour
Price: $9.10
Price 24-Hour Time-Series Raw Data
The stock price has reached a 52-week and all-time high, strongly supported by the FDA's Breakthrough Therapy Designation for Zovegalisib and a surge in social media engagement, particularly on X.
24-Hour: 2.35% 7-Day: 5.66% 30-Day: 24.35%
1-Year High: $9.40 on 2026-02-17
1-Year Low: $3.10 on 2025-06-17
AltRank: [-----]
AltRank 24-Hour Time-Series Raw Data
Relay Therapeutics, Inc. (RLAY) is currently AltRank #1,620 based on combined combined social and market metrics
Daily Average: [-----]
[--] Week: [-----] [----]
1-Year High: [-----] on 2026-01-23
1-Year Low: [---] on 2026-01-24
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] +17
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2026-02-03
1-Year Low: [--] on 2025-09-20
Engagements: [---] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [-----]
[--] Week: [------] -45%
[--] Month: [------] -4.60%
[--] Months: [-------] -32%
[--] Year: [---------] -37%
1-Year High: [------] on 2025-08-08
1-Year Low: [--] on 2025-11-01
Engagements by network (24h): News: [--] X: [---] Reddit: [--] YouTube: [--]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] -6.70%
1-Year High: [---] on 2025-08-12
1-Year Low: [--] on 2025-04-27
Mentions by network (24h): News: [--] X: [--] Reddit: [--] YouTube: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Relay Therapeutics, Inc. (RLAY) in the last [--] hours which is up 46% from [--] in the previous [--] hours
Daily Average: [--]
[--] Week: [---] -3.70%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-12-28
The most influential creators that mention Relay Therapeutics, Inc. in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @mariostario2019 | [--] | [--] | [--] | [--] |
| @CharlieQuiTrade | [--] | [--] | [--] | [--] |
| @victorystocktv | [--] | [------] | [--] | [--] |
| @BuyTheUgly | [--] | [--] | [--] | [--] |
| @Brad_E_Schulz | [--] | [------] | [--] | [--] |
| @SteveDJacobs | [--] | [------] | [--] | [--] |
| @broadinstitute | [--] | [------] | [--] | [--] |
| @moonshot_usa | [--] | [-----] | [--] | [--] |
Sentiment: 86%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 86%
Daily Average: 79%
[--] Week: 100% +56%
[--] Month: 70% -3%
[--] Months: 70% -27%
[--] Year: 70% +3%
1-Year High: 100% on 2025-02-19
1-Year Low: 17% on 2025-05-30
Most Supportive Themes:
- FDA Breakthrough Therapy Designation: (50%) The FDA granted Breakthrough Therapy Designation to Zovegalisib for PIK3CA-mutant HR+/HER2- advanced breast cancer.
- Positive Analyst Ratings: (20%) Oppenheimer provided positive analyst ratings, contributing to a positive outlook.
- High Engagement on X: (15%) The majority of engagements are coming from X, indicating a strong presence and discussion on this platform.
Most Critical Themes:
- Low YouTube Engagement: (-5%) YouTube contributes a very small fraction of engagements and mentions, suggesting limited reach or interest on this platform.
- Decreasing Creators: (-10%) The number of unique social accounts posting about the token has decreased, indicating a potential slowdown in community-driven content creation.
Social Dominance: 0.00328%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00328%
Daily Average: 0.00647%
[--] Week: 0.00274% -0.00206%
[--] Month: 0.0045% +0.0016%
[--] Months: 0.0045% -0.0014%
[--] Year: 0.0045% -0.0002999999999999999%
1-Year High: 0.051% on 2025-08-12
1-Year Low: 0.0012% on 2025-10-31
Market Dominance: 0.0018%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.0018%
Daily Average: 0%
1-Year High: 0.071% on 2026-02-06
1-Year Low: 0.00185% on 2026-02-17
Market Cap: $1,581,566,763
Market Cap 24-Hour Time-Series Raw Data
Current Value: $1,581,566,763
Daily Average: $1,411,758,971
[--] Week: $1,625,763,971 +5%
[--] Month: $1,625,763,971 +28%
1-Year High: $1,625,763,971 on 2026-02-17
1-Year Low: $1,273,919,530 on 2026-01-16
Top Relay Therapeutics, Inc. Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"1412_CFI_ALTO $AAOI $ABAT $ALLO $ANNX $ASTI $BLMN $CHRS $ERAS $FLNC $GPRE $HUT $IBRX $ICHR $IRWD $MRNA $NEOG $NVAX $PACB $PALI $PTEN $RAPT $RLAY $RUN $SGML $SIDU $TNGX $TXG $VKTX $VSAT $VTYX"
X Link @Tautilas 2026-02-16T10:13Z [----] followers, [---] engagements
"Biotech Stock Catalyst Watchlist for Q1 [----] Probability of approval score card is below $ETON PDUFA $OCUL Phase [--] $TARA Phase [--] $REGN BLA $ASND PDUFA $XOMA Phase [--] $GOSS Phase [--] $CAPR BLA $RLAY Phase 1/2 $RYTM PDUFA $TELO Pre-clinical $RCKT PDUFA $LNTH PDUFA $ABVX Phase [--] $ALMS Phase [--] $MGX Preclinical $CTNM Phase 1b $SXTP Phase [--] $NAYA Phase 1/2a $ACAD Phase [--] https://twitter.com/i/web/status/2022341817685975187 https://twitter.com/i/web/status/2022341817685975187"
X Link @Biopharma_Watch 2026-02-13T16:07Z [----] followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing